Is Ibogaine Legal in the US? Schedule I Facts (Not Legal Advice)

Definition box

Definition: Is ibogaine legal in the US? Under federal controlled-substances law, ibogaine is listed as a Schedule I substance (see 21 CFR 1308.11). It is not FDA-approved for addiction, depression, PTSD, detoxification, or any other indication. IV ibogaine infusion—psychoactive intravenous ibogaine under physician supervision in a medical infusion setting—does not change U.S. federal scheduling or create an FDA-approved therapy pathway by branding alone. Evidence gap: Most published clinical literature people cite (Cherian et al., *Nature Medicine* 2024; Knuijver et al., *Addiction* 2021) describes oral ibogaine (± IV magnesium/support), not controlled IV-psychoactive approval evidence. Cardiac QTc risk remains medically central wherever programs operate. This page is educational—not legal advice.

Quotable answer (54 words)

Ibogaine is Schedule I under U.S. federal law and is not FDA-approved for any indication. IV ibogaine infusion means physician-supervised intravenous psychoactive delivery in a medical setting with cardiac monitoring; that clinical framing does not make ibogaine federally legal or FDA-approved. Most published research remains oral-route. This is not legal advice.

What “Schedule I” means in plain language

Schedule I placement (federal) generally signals that a substance is treated as having a high potential for abuse, no currently accepted medical use in treatment in the United States under the Controlled Substances Act framework as administered, and a lack of accepted safety for use under medical supervision as defined by that scheduling system.

For readers, the practical education points are:

1. Ibogaine is federally controlled as Schedule I (21 CFR 1308.11 includes ibogaine).
2. Not FDA-approved means there is no FDA-approved ibogaine product labeled for opioid detox, depression, PTSD, or related claims.
3. Clinic marketing abroad is not the same as U.S. approval or domestic legality.
4. Route (oral vs IV) does not erase scheduling.

This article does not interpret criminal exposure, state nuances, research exemptions, or travel law. For personal legal questions, consult a qualified attorney. For medical screening education, see /safety-and-screening.

What this site’s entity is (and is not)

IV ibogaine infusion on ibogaineinfusion.com means psychoactive intravenous ibogaine under physician supervision—journey parallel to ketamine infusion clinics (consult → cardiac screen → monitored infusion → integration). That entity lock is about medical model honesty, not a claim that U.S. law treats ibogaine like FDA-cleared clinic ketamine protocols for depression.

| Framing | Accurate? | |---------|-----------| | “IV infusion under MD supervision” as a care-model description | Yes for this brand’s entity education | | “Therefore legal/FDA-approved in the US like clinic ketamine” | No | | “Oral papers prove IV is an approved medicine” | No | | “Schedule I means zero research can ever occur anywhere” | Oversimplified—research frameworks exist in limited contexts; still not consumer approval |

Entity hub: /what-is-ibogaine-infusion. Journey: /how-it-works. Oral vs IV evidence teaching: /blog/ibogaine-oral-vs-iv.

FDA approval vs “people study it” vs “clinics offer it abroad”

These are different buckets people mash together in search:

1) FDA-approved medicine Ibogaine is **not** FDA-approved for any indication. Do not market or imply labeled drug status.

2) Published research interest Observational and limited clinical literature exists—largely **oral** administration. Examples:

• **Cherian et al., *Nature Medicine* 2024 — open-label oral ibogaine + IV magnesium in a veteran/TBI observational protocol; RCTs needed; not** IV-ibogaine approval evidence.
• **Knuijver et al., *Addiction* 2021** — oral HCl; QTc safety signals.
• Mosca et al. systematic review — limited RCTs; cardiotoxicity concerns.

Research interest ≠ FDA approval ≠ U.S. consumer legality.

3) Programs outside the United States Many public discussions reference treatment tourism (commonly Mexico and other jurisdictions). “Available abroad” means **foreign operation under local rules**—not U.S. Schedule I repeal and not uniform specialty regulation. Travel raises separate legal, medical, and logistical issues this page does not advise on.

Why legality searches spike next to safety and cost

People asking is ibogaine legal in the US often also ask:

• Is it safe / what ECG is required? → /blog/ibogaine-ecg-checklist, /blog/is-ibogaine-safe-screening-cardiac-risk
• How much do programs cost? → /blog/cost-of-ibogaine-treatment
• How does it compare to ketamine clinics? → /blog/ibogaine-vs-ketamine-for-addiction
• How do I vet clinics? → /blog/how-to-choose-an-ibogaine-clinic

Legal status does not remove QTc / arrhythmia medical risk. Unsupervised use is dangerous regardless of jurisdiction narratives.

Support IV vs psychoactive IV (legal pages still need this)

Even on a legality spoke, YMYL accuracy requires the distinction:

• Support IV: fluids, electrolytes (e.g., magnesium), antiemetics, emergency medications.
• Psychoactive IV: ibogaine itself infused intravenously.

MISTIC’s IV magnesium does not mean Cherian 2024 studied psychoactive IV ibogaine. Clinics that blur this while citing “Stanford/Nature Medicine legality vibes” fail evidence honesty (/blog/stanford-ibogaine-mistic, /blog/cheap-ibogaine-clinic-red-flags).

Condition interest without cure or access claims

Public interest clusters around addiction, depression, and PTSD:

• /ibogaine-for-addiction
• /ibogaine-for-depression
• /ibogaine-for-ptsd

Those pages discuss research interest and limits—not guaranteed outcomes and not U.S. prescribing pathways. Systematic reviews emphasize limited RCTs and safety concerns. No cure language.

Practical diligence checklist (education, not counsel)

1. Assume federal Schedule I + no FDA approval unless a licensed attorney and clinician tell you otherwise for a specific regulated research context.
2. Do not treat foreign program availability as U.S. legality.
3. Require written psychoactive route (oral vs IV) and monitoring plan before deposits.
4. Prioritize cardiac screening education (/safety-and-screening).
5. Treat “legal loophole / church exemption / gray area” marketing as a diligence stop—get independent legal advice; this site will not endorse workaround narratives.
6. Soft clinical next step after education: /apply (screening consult interest—not a promise of U.S. treatment legality).

Soft CTA

If you are educating yourself on U.S. scheduling facts while evaluating whether a physician-supervised IV ibogaine infusion discussion is even appropriate medically, start with /safety-and-screening and /faq, then request a confidential screening consult via /apply. Bring questions about route clarity and cardiac monitoring—not assumptions of FDA approval.

FAQ

Is ibogaine legal in the US? Ibogaine is a U.S. federal **Schedule I** controlled substance (21 CFR 1308.11) and is **not FDA-approved** for any indication. This is educational information, not legal advice.

Does IV delivery make ibogaine legal or FDA-approved? No. Psychoactive IV framing describes a medical-model entity; it does not create FDA approval or erase Schedule I status.

Is ibogaine the same legally as ketamine clinic treatment? No. Ketamine has approved anesthetic uses and established clinic pathways for some psychiatric protocols under different regulatory facts. Ibogaine is Schedule I and not FDA-approved. See /blog/ibogaine-vs-ketamine-for-addiction.

Can research papers make it legal to buy online? Published research does not authorize consumer purchase or unsupervised use. Online sourcing is unsafe and legally risky; this page does not provide sourcing advice.

Are foreign ibogaine clinics “FDA approved abroad”? FDA approval is a U.S. regulatory concept. Foreign programs operate under local rules; they are not FDA-approved ibogaine medicines by virtue of existing.

Does Schedule I mean no cardiac screening is needed if I travel? No. Medical risk (including QTc prolongation) is independent of tourism narratives. See /safety-and-screening.

Is most legal/medical literature about oral or IV ibogaine? Most cited clinical literature is **oral** (± support IV such as magnesium). Controlled psychoactive IV evidence is sparse (/blog/ibogaine-oral-vs-iv).

Where can I read non-legal next steps? /what-is-ibogaine-infusion, /how-it-works, /safety-and-screening, /apply.

Medical disclaimer

Educational only—not legal advice, not medical advice, not travel advice. Ibogaine is Schedule I in the United States and not FDA-approved. It carries serious risks including cardiac arrhythmia. Do not self-administer. Consult licensed attorneys for legal questions and licensed clinicians for medical decisions. Soft CTAs: /safety-and-screening, /apply.

Sources (selected)

1. 21 CFR 1308.11 — Schedule I controlled substances (ibogaine listed).
2. U.S. DEA scheduling materials referencing ibogaine as Schedule I (controlled substances framework).
3. Cherian K.N. et al. *Nature Medicine*. 2024 — open-label oral ibogaine + IV magnesium (not approval evidence; not IV-psychoactive proof).
4. Knuijver T. et al. *Addiction*. 2021 — oral ibogaine HCl; QTc observational findings.
5. Mosca A. et al. *Current Neuropharmacology* — systematic review; limited RCTs; cardiotoxicity concerns.